Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

Published:2024-03-01 Issue:5 Volume:16 Page:1026
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Wu Yanyuan¹²^ORCID,Sarkissyan Marianna¹,Ogah Ochanya¹,Kim Juri¹,Vadgama Jaydutt V.¹²^ORCID

Affiliation:

1. Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA

2. Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA

Abstract

In the original publication, there was a mistake in Figure 4B as published [...]

Funder

National Cancer Institute

National Institute on Minority Health and Health Disparities

Publisher

MDPI AG

Link

https://www.mdpi.com/2072-6694/16/5/1026/pdf

Reference1 articles.

1. Wu, Y., Sarkissyan, M., Ogah, O., Kim, J., and Vadgama, J.V. (2020). Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers, 12.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP